The US represents a significant market within North America, driven by the country's large-scale agricultural industry, established horticulture sector, and increasing emphasis on efficient crop production. Cytokinins are used as plant growth regulators to influence cell division, shoot development, plant growth, and crop quality. Growing investments in greenhouse cultivation, precision...
The US represents a major market within North America, driven by strong hospital and laboratory networks, rising chronic disease burden, and growing demand for safe and efficient blood-sampling procedures. Technological advancements in blood collection devices are further supporting market growth.
According to The Insight Partners, The global Blood Collection Needles Market is witnessing...
The US represents a key market in North America, driven by high spending on pet healthcare, greater awareness of canine atopic dermatitis, and strong availability of advanced veterinary treatments. The country’s established veterinary care network and presence of leading animal-health companies further support market growth.
According to The Insight Partners, The Canine Atopic Dermatitis...
The US represents a major market within North America, driven by innovative cancer treatments, strategic collaborations, advanced clinical research, and increasing adoption of targeted and personalized therapies. The country’s strong oncology drug pipeline is expected to support continued market growth.
The Cancer Therapeutics and Supportive Care Drugs Market is witnessing strong...
The US represents a key market within North America, supported by expanding oncology drug pipelines, advanced clinical research, and increasing adoption of personalized and targeted therapies for leukemia, lymphoma, and myeloma. Recent regulatory activity, including new approvals for multiple myeloma treatments, is further strengthening innovation and treatment options.
The Blood Cancer Drugs...
The US Blood Component Utilization Market represents the dominant national market within North America, estimated to account for 72–76% of the regional market in 2025 and projected to grow at a 3.80–4.20% CAGR through 2034. Growth is supported by the country's extensive network of academic medical centers, trauma systems, cancer centers, blood services, and specialized transfusion...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
